JP2006516583A5 - - Google Patents

Download PDF

Info

Publication number
JP2006516583A5
JP2006516583A5 JP2006501686A JP2006501686A JP2006516583A5 JP 2006516583 A5 JP2006516583 A5 JP 2006516583A5 JP 2006501686 A JP2006501686 A JP 2006501686A JP 2006501686 A JP2006501686 A JP 2006501686A JP 2006516583 A5 JP2006516583 A5 JP 2006516583A5
Authority
JP
Japan
Prior art keywords
solution
pharmaceutically acceptable
palonosetron
acceptable salt
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006501686A
Other languages
English (en)
Japanese (ja)
Other versions
JP5461763B2 (ja
JP2006516583A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/000888 external-priority patent/WO2004067005A1/en
Publication of JP2006516583A publication Critical patent/JP2006516583A/ja
Publication of JP2006516583A5 publication Critical patent/JP2006516583A5/ja
Application granted granted Critical
Publication of JP5461763B2 publication Critical patent/JP5461763B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006501686A 2003-01-30 2004-01-30 パロノセトロン液状医薬製剤 Expired - Lifetime JP5461763B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44435103P 2003-01-30 2003-01-30
US60/444,351 2003-01-30
PCT/EP2004/000888 WO2004067005A1 (en) 2003-01-30 2004-01-30 Liquid pharmaceutical formulations of palonosetron

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011165212A Division JP5551658B2 (ja) 2003-01-30 2011-07-28 パロノセトロン液状医薬製剤

Publications (3)

Publication Number Publication Date
JP2006516583A JP2006516583A (ja) 2006-07-06
JP2006516583A5 true JP2006516583A5 (cg-RX-API-DMAC7.html) 2007-03-15
JP5461763B2 JP5461763B2 (ja) 2014-04-02

Family

ID=32825409

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006501686A Expired - Lifetime JP5461763B2 (ja) 2003-01-30 2004-01-30 パロノセトロン液状医薬製剤
JP2011165212A Expired - Lifetime JP5551658B2 (ja) 2003-01-30 2011-07-28 パロノセトロン液状医薬製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011165212A Expired - Lifetime JP5551658B2 (ja) 2003-01-30 2011-07-28 パロノセトロン液状医薬製剤

Country Status (41)

Country Link
US (9) US7947724B2 (cg-RX-API-DMAC7.html)
EP (2) EP2008659A1 (cg-RX-API-DMAC7.html)
JP (2) JP5461763B2 (cg-RX-API-DMAC7.html)
KR (1) KR101113084B1 (cg-RX-API-DMAC7.html)
CN (2) CN1758911A (cg-RX-API-DMAC7.html)
AP (1) AP2110A (cg-RX-API-DMAC7.html)
AR (1) AR042977A1 (cg-RX-API-DMAC7.html)
AT (1) ATE410167T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004208505C1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0407121B8 (cg-RX-API-DMAC7.html)
CA (5) CA2573194A1 (cg-RX-API-DMAC7.html)
CR (1) CR7921A (cg-RX-API-DMAC7.html)
CY (1) CY1108660T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004016967D1 (cg-RX-API-DMAC7.html)
DK (1) DK1601359T3 (cg-RX-API-DMAC7.html)
EA (1) EA014066B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP055938A (cg-RX-API-DMAC7.html)
ES (1) ES2315635T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20084445B (cg-RX-API-DMAC7.html)
HR (1) HRP20050676B1 (cg-RX-API-DMAC7.html)
IL (1) IL169859A (cg-RX-API-DMAC7.html)
IS (1) IS7984A (cg-RX-API-DMAC7.html)
JO (1) JO2735B1 (cg-RX-API-DMAC7.html)
MA (1) MA27710A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05008028A (cg-RX-API-DMAC7.html)
MY (1) MY144036A (cg-RX-API-DMAC7.html)
NO (1) NO329500B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ541533A (cg-RX-API-DMAC7.html)
PA (1) PA8594801A1 (cg-RX-API-DMAC7.html)
PE (1) PE20050066A1 (cg-RX-API-DMAC7.html)
PL (1) PL378398A1 (cg-RX-API-DMAC7.html)
PT (1) PT1601359E (cg-RX-API-DMAC7.html)
PY (1) PY0401585A (cg-RX-API-DMAC7.html)
RS (1) RS20050578A (cg-RX-API-DMAC7.html)
SI (1) SI1601359T1 (cg-RX-API-DMAC7.html)
TN (1) TNSN05180A1 (cg-RX-API-DMAC7.html)
TW (1) TWI342212B (cg-RX-API-DMAC7.html)
UA (1) UA90449C2 (cg-RX-API-DMAC7.html)
UY (1) UY28175A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004067005A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200506917B (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5690461B2 (ja) * 2002-11-15 2015-03-25 ヘルシン ヘルスケア ソシエテ アノニム 化学療法誘導嘔吐を治療するためのパロノセトロン
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
TWI355936B (en) * 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
CN100336508C (zh) * 2005-02-23 2007-09-12 重庆医药工业研究院有限责任公司 一种稳定的帕洛诺司琼注射液
CN100455286C (zh) * 2006-11-21 2009-01-28 深圳海创医药科技发展有限公司 帕洛诺司琼注射液及其制备方法
US9061076B2 (en) 2007-05-25 2015-06-23 North Carolina State University Viral nanoparticle cell-targeted delivery platform
US20100048607A1 (en) * 2008-08-25 2010-02-25 Chandrashekhar Kocherlakota Formulations comprising palonosetron
EP2364138A2 (en) 2008-12-08 2011-09-14 Teva Pharmaceutical Industries Ltd. Palonosetron formulation
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
EP2499137A1 (en) 2009-11-13 2012-09-19 Helsinn Healthcare S.A. Palonosetron metabolites
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
PE20121483A1 (es) 2009-11-18 2012-12-02 Helsinn Healthcare Sa Composiciones para tratar nausea y vomito centralmente mediados
KR101368587B1 (ko) * 2010-12-27 2014-03-05 주식회사 삼양바이오팜 오심 또는 구토 방지용 조성물
WO2013057554A2 (en) 2011-10-18 2013-04-25 Helsinn Healthcare Sa Therapeutic combinations of netupitant and palonosetron
EP3087987A4 (en) 2013-12-23 2017-08-02 Samyang Biopharmaceuticals Corporation Pharmaceutical composition containing palonosetron
CN104784107A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种盐酸托烷司琼口服液的制备方法
KR20160128573A (ko) * 2015-04-29 2016-11-08 주식회사 삼양바이오팜 약제학적 패키지
HRP20200196T1 (hr) * 2016-06-06 2020-05-01 Helsinn Healthcare Sa Fiziološki balansirane injektabilne formulacije fosnetupitanta
JP6768404B2 (ja) * 2016-08-12 2020-10-14 武田テバファーマ株式会社 パロノセトロン又はその薬学的に許容される塩を含む医薬組成物
JP6705348B2 (ja) * 2016-09-23 2020-06-03 ニプロ株式会社 液体製剤、及び、パロノセトロンの安定性を向上する方法
JP6642377B2 (ja) * 2016-10-25 2020-02-05 ニプロ株式会社 液体製剤、及び、パロノセトロンの安定性を向上する方法
KR101802183B1 (ko) * 2016-11-16 2017-11-28 주식회사 유영제약 팔로노세트론을 활성성분으로 함유하는 약제학적 조성물
EP3554489A4 (en) 2016-12-15 2020-06-17 Evoke Pharma, Inc. TREATMENT FROM MODERATE TO HEAVY GASTROPARESIS
WO2019038656A1 (en) 2017-08-21 2019-02-28 Leiutis Pharmaceuticals Pvt, Ltd NEW TRIPLE COMBINATION FORMULATIONS FOR ANTIEMETIC THERAPY
US11433021B2 (en) * 2018-01-12 2022-09-06 Orion Corporation Palonosetron for the treatment or prevention of nausea and vomiting
JP7090845B2 (ja) * 2018-08-03 2022-06-27 高田製薬株式会社 パロノセトロン含有液体組成物
JP7438802B2 (ja) * 2020-03-23 2024-02-27 シオノギファーマ株式会社 パロノセトロン含有組成物
TW202428273A (zh) 2023-01-03 2024-07-16 瑞士商赫爾辛保健公司 奈妥吡坦(netupitant)及帕洛諾司瓊(palonosetron)的液態口服調配物

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
US4695578A (en) 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3687080T2 (de) 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
US4937247A (en) 1985-04-27 1990-06-26 Beecham Group P.L.C. 1-acyl indazoles
US5240954A (en) 1985-06-25 1993-08-31 Glaxo Group Limited Medicaments
GB8516083D0 (en) 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US5578628A (en) 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
US4906755A (en) 1986-11-03 1990-03-06 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds
US5360800A (en) 1987-09-03 1994-11-01 Glaxo Group Limited Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives
US5011846A (en) 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
GB8914804D0 (en) 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5344658A (en) 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
AU642178B2 (en) * 1989-11-28 1993-10-14 Roche Palo Alto Llc New tricyclic compounds
ES2149305T3 (es) 1991-05-03 2000-11-01 Searle & Co Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y procedimientos de uso.
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
GB9305593D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Pharmaceuticals
US5567818A (en) * 1994-07-08 1996-10-22 Syntex (U.S.A.) Inc. Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein
GB9423588D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423511D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
JP3845902B2 (ja) * 1996-07-09 2006-11-15 ソニー株式会社 磁気記録再生装置
ATA156496A (de) 1996-09-03 1997-10-15 Nycomed Austria Gmbh Pharmazeutische zusammensetzung
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US20030095926A1 (en) 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
US6294548B1 (en) * 1998-05-04 2001-09-25 Hoffmann-La Roche Inc. Multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
DE19833119A1 (de) 1998-07-23 2000-01-27 Roche Diagnostics Gmbh Spritzfertige Injektionslösungen enthaltend Carvedilol
BR9914799A (pt) * 1998-10-27 2001-07-10 Alcon Lab Inc Sistema conservante para composições farmacêuticas administráveis topicamente contendo um sabão de ácido graxo/aminoácido
RU2003121304A (ru) 2000-12-20 2005-01-27 Бристол-Маерс Сквибб Компани (Us) Замещенные пиридоиндолы в качестве агонистов и антагонистов серотонина
CA2446837C (en) 2001-05-11 2012-01-03 Mitsubishi Pharma Corporation Stable high-concentration injection containing pyrazolone derivative
AU2003237657A1 (en) 2002-05-24 2003-12-12 Epidauros Biotechnologie Ag Means and methods for improved treatment using "setrones"
JP5690461B2 (ja) * 2002-11-15 2015-03-25 ヘルシン ヘルスケア ソシエテ アノニム 化学療法誘導嘔吐を治療するためのパロノセトロン
WO2004056324A2 (en) 2002-12-19 2004-07-08 Bristol-Myers Squibb Company Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
ES2285407T3 (es) 2003-01-13 2007-11-16 Dynogen Pharmaceuticals Inc. Metodo para el tratamiento de nauseas, vomitos, arcadas o cualquiera de sus combinaciones.
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
TWI355936B (en) * 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride

Similar Documents

Publication Publication Date Title
EP3171868B1 (en) Packaged acetaminophen injection solution preparation
JP5551658B2 (ja) パロノセトロン液状医薬製剤
US20100179184A1 (en) Article of manufacture for prasugrel
JP6741286B2 (ja) 包装されたアセトアミノフェン注射液製剤の製造方法
UA73584C2 (en) High concentrated stable solutions of meloxicam
RU2005114485A (ru) Стабилизированный фармацевтический препарат, включающий аморфное активное вещество
JP2006316075A5 (cg-RX-API-DMAC7.html)
CN104812392A (zh) 稳定的培美曲塞制剂
JP2008521884A5 (cg-RX-API-DMAC7.html)
KR20020081293A (ko) 페메트렉시드를 모노티오글리세롤 l-시스테인 또는티오글리콜산과 함께 포함하는 제약 조성물
US6294548B1 (en) Multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
CN101081301A (zh) 含有培美曲塞的药物组合物
CN117838984A (zh) 一种含肾上腺素药液的预灌封装置、组合物及其制备方法
JP2020510619A5 (cg-RX-API-DMAC7.html)
JP2020522564A (ja) アセトアミノフェンと、任意に1つ以上のnsaidとを含む、溶存酸素量が低い組成物を作製する方法、及びそれにより得られる組成物
JP5860979B2 (ja) 5−ヒドロキシ−1h−イミダゾール−4−カルボキサミドもしくはその塩またはその水和物を含む固形製剤の包装体
JP7098925B2 (ja) 固形製剤及び非晶質体の安定性を向上させる方法
JP2012240921A (ja) 発泡性組成物
TH71263A (th) สูตรผสมทางเภสัชกรรมชนิดเหลวของพาโลนอเซทรอน
CO5271647A1 (es) Metodo para prevenir la diarrea
TW201603801A (zh) 被包裝的乙醯胺苯酚注射溶液製劑
TW201340969A (zh) 有效hcv抑制劑之穩定醫藥調配物
CN103655529B (zh) 一种抗组胺和促进睡眠的组合物及软胶囊
JP2011126856A (ja) スマトリプタン含有内用液剤
JPH119655A (ja) 注射剤